Stockreport

AGTC Presents Data Demonstrating Efficiency of its AAV Vectors for Ocular Gene Therapy Even in the Presence of Anti-AAV Antibodies

Applied Genetic Technologies Corporation  (AGTC) 
Last applied genetic technologies corporation earnings: 2/5 04:15 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.agtc.com/investor-relations
PDF -Data support safety and potential clinical utility of AGTC’s ocular gene therapy candidates regardless of patients’ AAV antibody status- GAINESVILLE, Fla., and CAMBR [Read more]